Detalles de la búsqueda
1.
Peg-IFNα combined with hepatitis B vaccination contributes to HBsAg seroconversion and improved immune function.
Virol J
; 21(1): 77, 2024 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555445
2.
Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha.
BMC Endocr Disord
; 23(1): 115, 2023 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37217910
3.
A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated-interferon alpha.
Hepatology
; 66(4): 1058-1066, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28407271
4.
Effect of Peg-interferon α-2a combined with Adefovir in HBV postpartum women with normal levels of ALT and high levels of HBV DNA.
Liver Int
; 35(6): 1692-9, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25438657
5.
[Efficacy of combination antiviral therapy following childbirth in pregnant HBV carriers receiving telbivudine for prevention of mother-to-child transmission].
Zhonghua Gan Zang Bing Za Zhi
; 23(11): 821-5, 2015 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-26743241
6.
Bone marrow suppression or active proliferation? An analysis of neutropenia after pegylated interferon treatment of patients with chronic hepatitis C.
Scand J Infect Dis
; 45(12): 939-43, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24090457
7.
[Efficacy and safety of peginterferon alfa-2a (40 kd) plus adefovir for 96 weeks in HBeAg-negative chronic hepatitis B patients].
Zhonghua Gan Zang Bing Za Zhi
; 21(7): 498-501, 2013 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-24074706
8.
[Changes in lymphocyte surface expression of CD8 and CD38 molecules in peripheral blood of inactive HBsAg carriers following pegylated interferon a-2a therapy].
Zhonghua Gan Zang Bing Za Zhi
; 21(12): 895-8, 2013 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-24636289
9.
The bidirectional relationship between periodontitis and diabetes: New prospects for stem cell-derived exosomes.
Biomed Pharmacother
; 165: 115219, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37531782
10.
Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance.
Front Immunol
; 13: 1028921, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36211341
11.
Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis.
Front Immunol
; 12: 779347, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34804072
12.
Baseline resistance-associated substitutions may impact DAA response among treatment failure chronic hepatitis C patients with pegylated interferon and ribavirin in real life.
Antivir Ther
; 25(5): 245-255, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32936785
Resultados
1 -
12
de 12
1
Próxima >
>>